TERT-BUTYL 2-ACETAMIDOETHYLCARBAMATE, 95.0%, 250mg

1,2,5-Tribromo-3-isopropylbenzene, 98%, 1g

3-[[[(1,1-DIMETHYLETHYL)DIMETHYLSILYL]OXY]METHYL]-1-(PHENYLMETHYL)-4-PIPERIDINONE, 95.0%, 100mg

4-Benzyloxazolidine-2,5-dione, 95.0%, 10g

N-(2-Acetamido)iminodiacetic Acid>98.0%(T)500g

N-BOC-N-METHYL-1,4-DIOXASPIRO[4.5]DECAN-8-AMINE, 95.0%, 1g

4-Oxo-4-phenylbutyric acid, 98.0%, 5g

1-(difluoromethyl)-1H-pyrazole-4-carboxylic acid, 5g

ETHYL 2-BROMO-4-CHLORO-1H-IMIDAZOLE-5-CARBOXYLATE, 95.0%, 250mg

Phase contrast slide set with 20x and S100x PLPHi IOS infinity corrected objectives and phase contrast rings for 20x/S100x

1-((TERT-BUTOXYCARBONYL)AMINO)-3,3-DIFLUOROCYCLOPENTANECARBOXYLIC ACID, 95.0%, 1g

2-Amino-4-phenylphenol>98.0%(GC)(T)25g

7-Methoxycoumarin, 95%, 5g